Jamil RT,Foris L.A.,Snowden J. .2023 .Proteus mirabilis Infections. StatPearls Publishing, : .
Oztiirk R.,Murt A. .2020 .Epidemiology of urological infections: A global burden. World J. Urol,, 38 : 2669-2679.
Jacobsen S.M,,DJ M.E.,Shirtliff M.E. .2008 .Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. , : .
Clin. Microbiol. Rev. . .. , 21 : 26-59.
Morris N.S.,DJ C.,Winters C.,Urol J. .1997 .Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br. , 80 : 58-63.
Wasfi L.,Fahmy L. .2020 .. , : .
. .Proteus mirabilis biofilm: Development and therapeutic strategies. Front. Cell. Infect. Microbiol, 10 : .
.2020 .. , 00414 : .
Hamilton A.L,M.A. Kamm S.C.,Ng M.,Morrison M. .2018 .. , : .
Clin. Microbiol. Rev, . .. , 31 : 17.
Drzewiecka D. .2016 .Significance and roles of Proteus spp. , : .
. .bacteria in natural environments. , 72 : 741-758.
Flemming H.C.,J. Wingender H.C. .2010 .The biofilm matrix. , : .
Nat. Rev. Microbiol. . .. , : 623-633.
Jones G.L,AD. Russell Z,Caliskan D.J.,Stickler D.J. .2005 .. , : .
. .A strategy for the control of catheter blockage by crystalline Proteus mirabilis biofilm using the antibacterial agent triclosan. Eur. Urol., 48 : 838-845.
. Chen Y.H.,Chen P.L.,Lu T.C.,Chen C.Y.,Lin C.Y. .2012 .Proteus mirabilis urinary tract infection and bacteremia: Riskfactors, clinical presentation, and outcomes. , : .
Microbiol J. . .. , 45 : 228-236.
Ferraro M.J. .2009 .Antimicrobial susceptibility testing: Areview of general principles and contemporary practices. Clin. Infect. Dis., 49 : 1749-1755.
. Harika K.,Shenoy V.P.,Narasimhaswamy N.,Chawla K. .2020 .Detection of biofilm production and its impact on antibiotic resistance profile of bacterial isolates from chronic wound infections. J. Global Infect. Dis., 12 : 129-134.
Berman M.L.,Enquist L.W. .1984 .Experiments with Gene Fusions. , 9780879691639 : 303.
. Serry F.M.,HK F.M.,Abdel-Latif S.E.,Gomaa H.A.,Abbas H.A. .2018 .. , : .
. .Antimicrobial resistance of clinical Proteus mirabilis isolated from different sources. Zagazig J. Pharm. Sci.,, 27 : 57-63.
. Schaffer J.N.,M.M. Pearson J.N. .2015 .Proteus mirabilis and urinary tract infections. Microbiol. Spectr, 3 : .
.2013 .. , : .
.2019 .Proteus mirabilis Overview. Methods and Protocols, (8) : 1-4.
. Kishore .2012 .identification & characterization of Proteus penneri-A missed rare pathogen. Indian J. Med. Res., 135 : 341-345.
. Pandey A,Madan M. .2014 .. , : .
. .Extended spectrum beta lactamase producing Proteus pennerr. Arare missed pathogen? Indian J. Pathol. Microbiol., 57 : 489-491.
. Cohen-Nahum K,Saidel-Odes K.,Riesenberg F.,Schlaeffer A.,Borer A. .2010 .Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection, 38 : 41-46.
Okesola A.O.,Adeniji T.W. .2010 .Pattern of extended spectrum beta-lactamase production among clinical isolates of Proteus species in Western Nigeria. World J. Med. Sci,, 5 : 94-97.
Obadire S.,Mitsan L.P.,Ige D.,Ugbomoiko D.,Odewusi O.C.,Oke O.C. .2022 .Prevalence and antibiotic susceptibility pattern of Proteus species isolated from clinical specimens from selected hospitals in Jigawa State, North-West Nigeria. , 0 : .
Med Sokoto J. . .. , 7 : 27-34.
Alabi ,Mendonga N.,Adeleke O.E.,G.J. da Silva O.E. .2017 .. , 0 : .
. .Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria. Health Sci, 17 : 356-365.
Adamus-Bialek W .2013 .. Kaca, : .
Mol. Biol. Rep. . .. , 40 : 3429-3435.
Maione A,Cirillo L.,Gambino E.,Gallo M.A. .2023 .Prevalence, resistance patterns and biofilm production ability of bacterial uropathogens from cases of community-urianarcytqrauctiinfrecteiodnsin South Italy. Pathogens, 12 : .
Fusco A,Coretti L,Savio V.,Buommino E.,Lembo F.,Donnarumma G. .2017 .Biofilm formation and immunomodulatory activity of Proteus mirabilis clinically isolated strains. Int.J.Mol. Sci, 18 : .
Jacobsen S.M.,ME. Shirtliff S.M. .2011 .Proteus mirabilis biofilms and catheter-associated urinary tract infections. , : .
Virulence . .. , 2 : 460-465.
Kim J.Y,Park Y.J.,S.I. Kim Y.J.,Lee S.0.,Lee K.Y.,Antimicrob K.Y. .2004 .Nosocomial outbreak by Proteus mirabilis producing extended-spectrum B-lactamaseVEB-1 in a Korean university hospital. , 54 : 1144-1147.
Sun S.,Wen L.,Zhao Q.,Xia Y.,Pan Y. .2020 .. , : .
Vet. Res BMC . .. , 16 : 512917.
Egbule O.S.,Ehwarieme A.D.,Owhe-Ureghe A.D. .2016 .. , : .
. .High rate of antibiotic resistance in a neonatal intensive care unit of a university hospital. Microbiol. Res. J. Int,, 15 : .
.2016 .. , : .
Egbule ,UB. .2016 .Owhe-Ureghe and EE. , 0 : .
. .Occurrence of multidrug resistance among £ coli 0157:H7 isolated from stool samples obtained from hospitalized children. J. Probiotics Health, 4 : .
Egbule .2019 .Multiple antibiotic resistances in Escherichia coliisolated from cattle and poultry faeces in Abraka, South-South Nigeria. Pertanika J. Trop. Agric. Sci., 42 : 585-594.
Egbule .2022 .Occurrence of extended spectrum beta-lactamases and Su/1in multi-drug resistant £scherichia coli and Salmonella isolated from poultry feeds. Sci. Afr, 18 : .
Algammal AM,Hashem H.R.,Alfifi H.F. Hetta N.S.,Sheraba H.,El-Tarabili H. .2021 .Ramadan and RM. , : .
. .attD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes ofemerging XDR and MDR-Proteus mirabilis. Sci.Rep, 11 : .
. .. , : 541598.
Iweriebor B. .2022 .The emergence of colistin-and imipenem-associated multidrug resistance in Escherichia coli isolates from retail meat. Pol.J. Microbiol., 71 : 519-528.
Ye Y,Han Y.,Chen Z.,Liu C.,Ming L. .2018 .. , : .
. .Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates. Exp. Ther. Med, 15 : 1143-1149.
Alqurashi E,Abulreesh H.H. .2022 .. , : .
. .public health significance. J. Pure Appl, 16 : 1550-1561.
Akortha O.S.,Egbule O.S. .2008 .Transfer of tetracycline resistance gene (tet) between replicons in some enteric bacteria of diarrhoeal origin from some hospitals in South-South, Nigeria. , 7 : 3178-3181.
Egbule .2016 .Antimicrobial resistance and B-lactamase production among hospital dumpsite isolates. J. Environ., : 05.
Prot . .. , 7 : 1057-1063.
Porreca A,D.D'Agostino D.,Romagnoli F. .2021 .The clinical effoifncitraofucranytoin for treating uncomplicated urinary tract infection in adults: A systematic review of randomized control trials. Urol. Int., 105 : 531-540.
van Driel AA,Wijma RA.,Stobberingh E.E.,Verbon A.,CP. Koch B. .2023 .Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: The impact of dosing regimen, age, and renal function on drug exposure. Eur. J. Clin. Pharmacol, 79 : 1043-1049.
Fair Y.,Tor Y. .2014 .Antibiotics and bacterial resistance inthe 21st century. Perspect. Med. Chem, 6 : 25-64.
Shirakawa M.,Kuroda S.,Suzuki M.,Ozawa M. .2020 .IncC plasmids isolated from healthy broilers in Japan. Antimicrob. Agents Chemother, 64 : .
. .. , : 19.
Lakhundi S.,Zhang K. .2018 .Methicillin-resistant Staphylococcusaureus:Molecular characterization, evolution, and epidemiology. Clin. Microbiol. Rev, 31 : .
. .. , : 18.